<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="protocol"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29070637</article-id><article-id pub-id-type="pmc">5665327</article-id><article-id pub-id-type="publisher-id">bmjopen-2017-017202</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2017-017202</article-id><article-categories><subj-group subj-group-type="heading"><subject>Evidence Based Practice</subject><subj-group><subject>Protocol</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1694</subject></subj-group></article-categories><title-group><article-title>Effects of photobiomodulation therapy in patients with chronic non-specific low back pain: protocol for a randomised placebo-controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tomazoni</surname><given-names>Shaiane Silva</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Luc&#x000ed;ola da Cunha Menezes</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>Layana de Souza</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Araujo</surname><given-names>Amanda Costa</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Nascimento</surname><given-names>Dafne Port</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>de Medeiros</surname><given-names>Fl&#x000e1;via Cordeiro</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Avanzi</surname><given-names>Marina Athayde</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib id="author-35429791" contrib-type="author"><name><surname>Costa</surname><given-names>Leonardo Oliveira Pena</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">
<institution content-type="department">Masters and Doctoral Programs in Physical Therapy</institution>, <institution>Universidade Cidade de S&#x000e3;o Paulo</institution>, <country>Brazil</country>
</aff><author-notes><corresp><label>Correspondence to</label> Dr&#x000a0;Shaiane Silva&#x000a0;Tomazoni; <email>shaiane.tomazoni@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>24</day><month>10</month><year>2017</year></pub-date><volume>7</volume><issue>10</issue><elocation-id>e017202</elocation-id><history><date date-type="received"><day>10</day><month>4</month><year>2017</year></date><date date-type="rev-recd"><day>04</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>17</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjopen-2017-017202.pdf"/><self-uri content-type="reviewers-comments-pdf" xlink:href="bmjopen-2017-017202.reviewer_comments.pdf"/><self-uri content-type="draft-revisions-pdf" xlink:href="bmjopen-2017-017202.draft_revisions.pdf"/><abstract><sec><title>Introduction</title><p>Low back pain (LBP) is one of the largest and most frequent public health problems worldwide. Photobiomodulation therapy (PBMT) is a frequently used non-pharmacological therapy for the treatment of musculoskeletal disorders. However, there is little high-quality scientific evidence that demonstrates the effectiveness of PBMT in the treatment of patients with chronic LBP in the short, medium and long term. Therefore, the objective of this clinical trial is to evaluate the effects of PBMT in patients with chronic non-specific LBP in the short, medium and long term.</p></sec><sec><title>Methods and analyses</title><p>This is a prospectively registered, two-arm randomised placebo-controlled trial with blinded patients, assessors and treatment providers. One hundred and forty-eight patients with chronic non-specific LBP will be recruited. Treatment sessions will be provided three times a week for 4 weeks (totaling 12 sessions) with patients receiving either placebo or active PBMT. For ethical reasons, all patients, regardless of treatment allocation, will also receive an information booklet based on &#x02018;The Back Book&#x02019;. Clinical outcomes will be measured at baseline, at the end of treatment, as well as 3, 6 and 12 months after randomisation. The primary outcomes will be pain intensity and disability measured after 12 sessions of treatment. The secondary outcomes will be pain intensity and disability measured at 3, 6 and 12 months after randomisation, in addition to specific disability and global perceived effect in all time points.</p></sec><sec><title>Ethics and dissemination</title><p>The study was approved by the Research Ethics Committee of Universidade Cidade de S&#x000e3;o Paulo. The results will be disseminated through scientific publications and presentations at national and international scientific meetings.</p></sec><sec><title>Trial registration number</title><p>
<ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/show/NCT03089424">NCT03089424</ext-link>.</p></sec></abstract><kwd-group><kwd>chronic low Back pain</kwd><kwd>photobiomodulation therapy</kwd><kwd>low-level laser therapy</kwd><kwd>Lllt</kwd><kwd>pbmt</kwd></kwd-group><funding-group><award-group id="funding-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001807</institution-id><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Strengths and limitations of this study</title></caption><list list-type="bullet"><list-item><p>The present study can be considered to have high methodological quality since it is a randomised, controlled and prospectively registered clinical trial.</p></list-item><list-item><p>One of the strengths of the study is that it is triple blinded, that is, outcome assessors, therapists and patients will be blinded to interventions over the course of the study.</p></list-item><list-item><p>The sample size was calculated to provide the appropriate statistical power to detect precise differences for the primary outcomes of the study.</p></list-item><list-item><p>In our study, we will test the effects of a single dose of photobiomodulation therapy (PBMT; ie, 24 Joules). PBMT is known to present a biphasic dose&#x02013;response pattern, that is, within a therapeutic window (dosage range), the effects of biostimulation can be observed. However, if dosages below or above this window are used, these effects may not be observed. Therefore, the application of only one dose of PBMT may be considered a limitation of this trial. However to minimise this limitation, we based the choice of our parameters using the best available evidence.</p></list-item></list></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p>Low back pain (LBP) is ranked as one of the most prevalent health problems and is highly associated with disability worldwide.<xref rid="R1" ref-type="bibr">1&#x02013;4</xref> It is estimated that about 12% of the world&#x02019;s population suffer from LBP.<xref rid="R5" ref-type="bibr">5</xref> Furthermore, LBP generates high levels of work absenteeism and excessive costs to health systems.<xref rid="R1" ref-type="bibr">1 2</xref> The prognosis of LBP is directly related to the duration of symptoms, with less favourable prognoses in patients with chronic LBP (ie, with a duration of symptoms longer than 3&#x02009;months).<xref rid="R6" ref-type="bibr">6&#x02013;10</xref> Therefore, the ideal treatment for chronic LBP represents a significant challenge, since there are no treatments that cure persistent LBP. However, several interventions provide low to moderate effects in reducing pain and disability on this population.<xref rid="R11" ref-type="bibr">11</xref> The existing treatments for LBP can be divided into three categories: (1) pharmacological therapies, which trigger several adverse effects with prolonged use<xref rid="R12" ref-type="bibr">12&#x02013;14</xref>; (2) non-pharmacological therapies, which minimise undesirable effects and are moderately effective in LBP<xref rid="R15" ref-type="bibr">15</xref> and surgery, used only when conservative treatment is not efficacious.<xref rid="R16" ref-type="bibr">16</xref> Several therapies can be used to treat LBP by controlling symptoms, minimising disability and improving the patients' quality of life.<xref rid="R17" ref-type="bibr">17</xref>
</p><p>Photobiomodulation therapy (PBMT) is a non-pharmacological intervention often used in the treatment of musculoskeletal disorders such as LBP.<xref rid="R18" ref-type="bibr">18&#x02013;21</xref> PBMT consists in applying a non-ionised form of light, which includes laser (light amplification by stimulated emission of radiation), light-emitting diodes and other lights with a broader spectrum ranging from visible to infrared.<xref rid="R22" ref-type="bibr">22</xref> Recent evidence<xref rid="R23" ref-type="bibr">23&#x02013;28</xref> suggests that PBMT triggers positive physiological effects, such as increased microcirculation,<xref rid="R23" ref-type="bibr">23</xref> increased ATP synthesis<xref rid="R24" ref-type="bibr">24 25</xref> stimulation of the mitochondrial respiratory chain,<xref rid="R24" ref-type="bibr">24 25</xref> stimulation of mitochondrial function<xref rid="R26" ref-type="bibr">26</xref> and factors that may influence the metabolism of various pathologies. In addition, there is evidence that PBMT reduces the release of both reactive oxygen species) and creatine kinase activity and also increases the production of antioxidants and heat shock proteins.<xref rid="R27" ref-type="bibr">27 28</xref>
</p><p>As PBMT has been successfully proven as an effective intervention for neck pain patients,<xref rid="R29" ref-type="bibr">29</xref> it is likely that PBMT could also be a reasonable option for patients with LBP. A range of previous trial have shown the effects of PBMT on acute, subacute and chronic LBP. Basford <italic>et al</italic><xref rid="R18" ref-type="bibr">18</xref> and Gur <italic>et al</italic><xref rid="R19" ref-type="bibr">19</xref> observed that PBMT appears to be effective in reducing pain and disability triggered by subacute and chronic LBP, respectively. While Konstantinovic <italic>et al</italic><xref rid="R20" ref-type="bibr">20</xref> and Vallone <italic>et al</italic><xref rid="R21" ref-type="bibr">21</xref> found that PBMT combined with non-steroidal anti-inflammatory drugs (NSAIDs) and exercise were efficient in reducing pain intensity in patients with acute and chronic LBP, respectively. In a recent systematic review, Glazov <italic>et al</italic><xref rid="R30" ref-type="bibr">30</xref> found a clinically significant reduction in pain intensity in chronic LBP in patients treated with PBMT, although a reliable conclusion was hindered by the high heterogeneity in the parameters of therapy application. Furthermore, a recent clinical practice guidelines<xref rid="R31" ref-type="bibr">31</xref> recommended the use of the PBMT as a possible non-pharmacological treatment for chronic LBP. On the other hand, another trial<xref rid="R32" ref-type="bibr">32</xref> did not detected differences between PBMT and placebo treatments on pain and disability in mixed sample of patients with acute and chronic LBP associated with lumbar disk degeneration. These findings show that there are still conflicts in the literature about PBMT in LBP. Therefore, high-quality and adequately powered trials are strongly needed.</p><p>Therefore, in spite of the positive results obtained in the aforementioned studies in favour of PBMT, some factors warrant further investigation with high-quality studies on the effects of PBMT applied in isolation in chronic non-specific LBP. Hence, it is necessary to conduct a high-quality, adequately powered, randomised placebo-controlled trial with outcomes have been measured at medium and long terms. Therefore, the objective of this study is to evaluate the effects of PBMT against placebo in patients with chronic non-specific LBP in the short, medium and long term for the outcomes of pain intensity, general and specific disability and global perceived effect.</p></sec><sec id="s2"><title>Methods and analyses</title><sec id="s2a"><title>Design</title><p>A randomised, triple-blinded (patients, therapists and outcome assessors), placebo-controlled trial will be performed. The protocol of this study has been prospectively registered on Clinicaltrials.gov (NCT03089424).</p></sec><sec id="s2b"><title>Study setting</title><p>The study will be conducted at the Centre for Excellence in Clinical Research in Physiotherapy of Universidade Cidade de S&#x000e3;o Paulo, Brazil.</p></sec><sec id="s2c"><title>Eligibility criteria</title><p>The study assessors will determine whether or not patients will be eligible to participate in the study based on patient history and clinical examination.</p><sec id="s2c1"><title>Inclusion criteria</title><list list-type="bullet"><list-item><p>Patients with non-specific chronic LBP, defined as pain or discomfort between the costal margins and inferior gluteal folds with or without referred pain to the lower limbs;</p></list-item><list-item><p>Persistent LBP for at least 3 months<xref rid="R33" ref-type="bibr">33</xref>;</p></list-item><list-item><p>Aged between 18 and 65 years;</p></list-item><list-item><p>Both genders.</p></list-item></list></sec><sec id="s2c2"><title>Exclusion criteria</title><list list-type="bullet"><list-item><p>Patients with severe skin diseases (eg, skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis and severe hives lupus);</p></list-item><list-item><p>Patients with LBP associated with nerve root compromise (measured by clinical examination of dermatomes, myotomes and reflexes)<xref rid="R34" ref-type="bibr">34 35</xref>;</p></list-item><list-item><p>Serious spinal pathologies such as fractures, tumours, inflammatory and infectious diseases;</p></list-item><list-item><p>Decompensated heart disease or metabolic disorders;</p></list-item><list-item><p>Previous spinal surgery;</p></list-item><list-item><p>Pregnancy.</p></list-item></list></sec></sec><sec id="s2d"><title>Interventions</title><p>For ethical reasons, on the first day of treatment, all groups will receive an information booklet on LBP called &#x02018;The Back Book&#x02019;<xref rid="R36" ref-type="bibr">36</xref> based on the recommendations of the European Guidelines.<xref rid="R35" ref-type="bibr">35 37</xref> The booklet can be accessed freely via internet and it has been translated into Portuguese by our research team. At each treatment session, patients will receive further explanations on the contents of the booklet. There is consistent evidence that The Back Book is useful for patients with LBP<xref rid="R38" ref-type="bibr">38</xref> and it has been used in clinical trials conducted by our research group.<xref rid="R39" ref-type="bibr">39 40</xref>
</p><p>Patients will then be randomly allocated to two groups to be submitted to the active PBMT or placebo interventions. The active and placebo PBMT will be performed using the same device and the irradiated sites will be the same in both therapies. To ensure blinding for therapists and patients, the device will emit the same sounds and the same information on the display regardless of the programmed mode (active or placebo). Furthermore, because the device produces a non-significant amount of heat,<xref rid="R41" ref-type="bibr">41</xref> the patients will not be able to know if active or placebo PBMT will be administered. The device was previously coded as active or placebo modes, and only one researcher not involved in the randomisation, treatment and evaluation is aware of these codes. Patients will undergo treatment (active PBMT or placebo) according to prior randomisation, three times a week (with a minimal interval of 24&#x02009;hours) for four consecutive weeks, totalling 12 therapy sessions. The choice of treatment frequency was based on Basford <italic>et al</italic>.<xref rid="R18" ref-type="bibr">18</xref> The total treatment (active PBMT or placebo) time will be 27&#x02009;min per patient. The patients will be positioned preferably in prone. However, in specific cases where patients do not tolerate this position due to pain, we will respect the patient&#x02019;s preferred positioning. Intervention specifications:</p><p>1. Active PBMT Group: The PBMT will be performed using the Multi Radiance Medical Super Pulsed Laser MR4 console (Solon, Ohio, USA), with the SE25 (emitter with an area of 4&#x02009;cm<sup>2</sup>) and LaserShower (emitter with an area of 20&#x02009;cm<sup>2</sup>) cluster probes as emitters. Nine sites will be irradiated on the patient&#x02019;s lumbar region. PBMT irradiation sites were chosen based on previous studies<xref rid="R18" ref-type="bibr">18&#x02013;21</xref> and to cover the largest possible area of the lumbar spine: three central sites on top of the spinous processes (between T11 and T12, L2 and L3, L5 and S1), using the SE25 (3000&#x02009;Hz of frequency, 3&#x02009;min of irradiation per site, 24.75 J per site, a totalising 74.25 J irradiated from SE25); in the same direction, but laterally, three sites on the left and three on the right (on the paravertebral muscles), using the LaserShower (1000&#x02009;Hz of frequency, 3&#x02009;min of irradiation per site, 24.30 J per site, a total of 145.80 J irradiated from LaserShower). At each treatment session, patients will receive a total dose of 220.05 J. At the end of the 12 treatments sessions, patients will receive a total dose of 2640.60 J. <xref ref-type="table" rid="T1">Table 1</xref> shows parameters for SE25 and LaserShower cluster probe. This PBMT application protocol was based on the study of Leal Junior <italic>et al</italic>.<xref rid="R42" ref-type="bibr">42</xref>
</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Parameters for SE25 and LaserShower cluster probe</p></caption><table frame="hsides" rules="groups"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="bottom" align="left" rowspan="1" colspan="1">SE25</td><td valign="bottom" align="left" rowspan="1" colspan="1">LaserShower</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of lasers</td><td valign="top" align="left" rowspan="1" colspan="1">1 super-pulsed infrared</td><td valign="top" align="left" rowspan="1" colspan="1">4 super-pulsed infrared</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Wavelength (nm)</td><td valign="top" align="left" rowspan="1" colspan="1">905 (&#x000b1;1)</td><td valign="top" align="left" rowspan="1" colspan="1">905 (&#x000b1;1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Frequency (Hz)</td><td valign="top" align="left" rowspan="1" colspan="1">3000</td><td valign="top" align="left" rowspan="1" colspan="1">1000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Peak power (W)&#x02014; each</td><td valign="top" align="left" rowspan="1" colspan="1">25</td><td valign="top" align="left" rowspan="1" colspan="1">12.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average mean optical output (mW)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">7.5</td><td valign="top" align="left" rowspan="1" colspan="1">1.25</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Power density (mW/cm<sup>2</sup>)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">17.05</td><td valign="top" align="left" rowspan="1" colspan="1">2.84</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Energy density (J/cm<sup>2</sup>)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">3.07</td><td valign="top" align="left" rowspan="1" colspan="1">0.511</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dose (J) - each</td><td valign="top" align="left" rowspan="1" colspan="1">1.35</td><td valign="top" align="left" rowspan="1" colspan="1">0.225</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Spot size of laser (cm<sup>2</sup>)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">0.44</td><td valign="top" align="left" rowspan="1" colspan="1">0.44</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of red LEDs</td><td valign="top" align="left" rowspan="1" colspan="1">4 red</td><td valign="top" align="left" rowspan="1" colspan="1">4 red</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Wavelength of red LEDs (nm)</td><td valign="top" align="left" rowspan="1" colspan="1">640 (&#x000b1;10)</td><td valign="top" align="left" rowspan="1" colspan="1">640 (&#x000b1;10)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Frequency (Hz)</td><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average optical output (mW)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1">15</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Power density (mW/cm<sup>2</sup>)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">16.67</td><td valign="top" align="left" rowspan="1" colspan="1">16.67</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Energy density (J/cm<sup>2</sup>)&#x02014; each</td><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">3</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dose (J) - each</td><td valign="top" align="left" rowspan="1" colspan="1">2.7</td><td valign="top" align="left" rowspan="1" colspan="1">2.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Spot size of red LED (cm<sup>2</sup>)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Number of infrared LEDs</td><td valign="top" align="left" rowspan="1" colspan="1">4 infrared</td><td valign="top" align="left" rowspan="1" colspan="1">4 infrared</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Wavelength of infrared LEDs (nm)</td><td valign="top" align="left" rowspan="1" colspan="1">875 (&#x000b1;10)</td><td valign="top" align="left" rowspan="1" colspan="1">875 (&#x000b1;10)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Frequency (Hz)</td><td valign="top" align="left" rowspan="1" colspan="1">16</td><td valign="top" align="left" rowspan="1" colspan="1">16</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average optical output (mW)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">17.5</td><td valign="top" align="left" rowspan="1" colspan="1">17.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Power density (mW/cm<sup>2</sup>)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">19.44</td><td valign="top" align="left" rowspan="1" colspan="1">19.44</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Energy density (J/cm<sup>2</sup>)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">3.5</td><td valign="top" align="left" rowspan="1" colspan="1">3.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dose (J)&#x02014;each</td><td valign="top" align="left" rowspan="1" colspan="1">3.15</td><td valign="top" align="left" rowspan="1" colspan="1">3.15</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Spot Size of LED (cm<sup>2</sup>)<sup>&#x02014;</sup>each</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td><td valign="top" align="left" rowspan="1" colspan="1">0.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Magnetic field (mT)</td><td valign="top" align="left" rowspan="1" colspan="1">35</td><td valign="top" align="left" rowspan="1" colspan="1">35</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Irradiation time per site (s)</td><td valign="top" align="left" rowspan="1" colspan="1">180</td><td valign="top" align="left" rowspan="1" colspan="1">180</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Total dose per site (J)</td><td valign="top" align="left" rowspan="1" colspan="1">24.75</td><td valign="top" align="left" rowspan="1" colspan="1">24.30</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Aperture of device (cm<sup>2</sup>)</td><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">20</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Application mode</td><td valign="top" align="left" rowspan="1" colspan="1">Cluster probe held stationary in skin contact with a 90-degree angle and slight pressure</td><td valign="top" align="left" rowspan="1" colspan="1">Cluster probe held stationary in skin contact with a 90-degree angle and slight pressure</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>LED, light-emitting diode.</p></fn></table-wrap-foot></table-wrap><p>2. Placebo PBMT Group: The placebo PBMT will be delivered using the same device that activates PBMT but without any emission of therapeutic dose. Patients will receive a total dose of 0 J in placebo mode. The placebo mode simulates the pragmatism of clinical practice and increases the credibility of the use of the equipment in relation to the treated patients. The placebo technique has already been widely used in other studies with patients with LBP,<xref rid="R40" ref-type="bibr">40 43&#x02013;48</xref> as well as in studies using PBMT.<xref rid="R41" ref-type="bibr">41 49 50</xref>
</p><p>
<xref ref-type="fig" rid="F1">Figure 1</xref> shows the PBMT irradiation sites.</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Photobiomodulation therapy irradiation sites.</p></caption><graphic xlink:href="bmjopen-2017-017202f01"/></fig><p>We will use two different emitters in PBMT (active or placebo) because we have different objectives in each application area, which consequently require different mechanisms of action. We will use the SE25 emitter on the spinous processes to inhibit pain. Considering the smaller area of this emitter (4&#x02009;cm<sup>2</sup>), the power density will be increased, which will consequently induce the triggering of inhibitory effects, such as a decrease in the axonal flow and thus analgesic effects.<xref rid="R51" ref-type="bibr">51 52</xref> In addition, the higher frequency used in this emitter will also increase the number of photons that will reach the target tissue, which will also promote the triggering of inhibitory effects and consequent analgesic effect. For the erector spinae muscles, we will use the LaserShower 50 (LS50) emitter to promote photobiostimulatory effects, considering the larger area of the device (20&#x02009;cm<sup>2</sup>), with consequent lower power density. In addition, this emitter has a lower frequency, which will consequently decrease the number of photons delivered to the target tissue. With these factors, we believe that we will promote an increase in the production of ATP,<xref rid="R24" ref-type="bibr">24 25</xref> an increase in microcirculation<xref rid="R23" ref-type="bibr">23</xref> and consequently a decrease in muscle fatigue and stiffness. This therapeutic strategy using different emitters and different frequencies showed positive effects in the reduction of non-specific knee pain in a previous study that used this same PBMT device and these same emitters<xref rid="R42" ref-type="bibr">42</xref>; however, the frequencies and doses were adapted for back pain patients.</p></sec><sec id="s2e"><title>Outcomes and blinding</title><p>Primary outcomes of the study will be obtained at baseline and immediately after the last treatment session (4 weeks). Secondary outcomes of the study will be obtained at baseline, at the end of treatment (4 weeks) and 3, 6 and 12 months after randomisation. These outcomes will be collected by an assessor who will not be aware of patient allocation to their treatment groups.</p><sec id="s2e1"><title>The primary outcomes of the study will be</title><list list-type="bullet"><list-item><p>Pain intensity measured by the Pain Numerical Rating Scale.<xref rid="R53" ref-type="bibr">53</xref> Pain Numerical Rating Scale evaluates pain intensity levels perceived by the patient on an 11-point scale ranging from 0 to 10, with 0 being &#x02018;no pain&#x02019; and 10 &#x02018;the worst possible pain&#x02019;.<xref rid="R53" ref-type="bibr">53</xref> Patients will be instructed to score the level of pain intensity based on the last 7 days.</p></list-item><list-item><p>Disability associated with LBP, as measured by the Roland-Morris Disability Questionnaire.<xref rid="R54" ref-type="bibr">54 55</xref> The questionnaire consists of 24 items that describe situations that patients may have difficulty performing on a daily basis due to LBP. The greater the number of affirmative answers is, the higher the level of functional disability associated with LBP.<xref rid="R53" ref-type="bibr">53 55</xref> Patients will be instructed to answer according to their condition on the day of administration of the questionnaire.</p></list-item></list></sec><sec id="s2e2"><title>The secondary outcomes of the study will be</title><list list-type="bullet"><list-item><p>Specific disability, as measured by the Patient-Specific Functional Scale.<xref rid="R53" ref-type="bibr">53</xref> The Patient-Specific Functional Scale is global and can be used for any part of the body. The measurement is done on an 11-point Likert scale for each activity, and the higher the average score is (ranging from 0 and 10 points), the better the patient&#x02019;s ability to perform the activities. The patients will be asked to identify up to three activities that they consider they are incapable of performing or that they have some difficulty performing.<xref rid="R53" ref-type="bibr">53 56 57</xref>
</p></list-item><list-item><p>Global perceived effect as measured by the Global Perceived Effect Scale.<xref rid="R53" ref-type="bibr">53</xref> Global Perceived Effect Scale is an 11-point Likert scale, ranging from &#x02212;5 to +5, that compares the patient&#x02019;s current condition to the onset of symptoms.<xref rid="R53" ref-type="bibr">53</xref> Positive scores represent improvement, while the negative scores represent worsening in relation to the onset of symptoms. Values closer to 5 mean greater intensity of this perception.<xref rid="R53" ref-type="bibr">53</xref>
</p></list-item><list-item><p>Pain intensity measured by the Pain Numerical Rating Scale.<xref rid="R53" ref-type="bibr">53</xref>
</p></list-item><list-item><p>Disability associated with LBP, as measured by the Roland-Morris Disability Questionnaire.<xref rid="R54" ref-type="bibr">54 55</xref>
</p></list-item></list></sec></sec><sec id="s2f"><title>Participant timeline</title><p>The Consolidated Standards of Reporting Trials flowchart summarising experimental procedures and patients are shown in <xref ref-type="fig" rid="F2">figure 2</xref>.</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Flow diagram of the study. PBMT, photobiomodulation therapy.</p></caption><graphic xlink:href="bmjopen-2017-017202f02"/></fig></sec><sec id="s2g"><title>Sample size</title><p>The sample calculation of the study was performed to detect a 1-point difference for the outcome pain intensity (as measured by the Pain Numerical Rating Scale),<xref rid="R53" ref-type="bibr">53</xref> with an estimated SD of 1.84 points and 4 points for the outcome disability associated with LBP (measured by the Roland-Morris Disability Questionnaire),<xref rid="R54" ref-type="bibr">54 55</xref> with an estimated SD of 4.9 points. A statistical power of 80% was considered for the two outcomes, with &#x003b1; of 5% and a possible sample loss of up to 15%. Therefore, a total of 148 patients will be required for the study.</p></sec><sec id="s2h"><title>Recruitment</title><p>Patients seeking treatment for chronic LBP will be recruited at primary or secondary care health services. We will partner with supervising clinicians at primary and secondary health services so that they will refer chronic non-specific LBP patients to our study for treatment.</p></sec><sec id="s2i"><title>Randomisation</title><p>Prior to initiation of treatment, patients will be randomised into their respective intervention groups. The randomisation will be generated by a computer program (Excel Office 2010) and performed by a participating researcher not involved with the recruitment or evaluation of patients. This same researcher will be responsible for programming the PBMT device according to the result of the randomisation. The PBMT device used in the present study will make the same sounds regardless of the programmed dose and mode (active PBMT or placebo PBMT). This researcher will be instructed not to disclose the programmed intervention to the therapist or any of the patients and other researchers involved in the study until its completion. Patient and therapist will be blinded throughout the treatment. Concealed allocation will be achieved through the use of sequentially numbered, sealed and opaque envelopes.</p></sec><sec id="s2j"><title>Data collection</title><p>The patients will be welcomed by the study&#x02019;s blinded assessor who will determine whether they will be eligible to participate in the study. Subsequently, a file will be completed with the patient&#x02019;s sociodemographic data and clinical history. Next, the primary outcomes and the secondary outcomes of the study will be collected. Then, all eligible patients will be randomised and allocated into two treatment groups: active PBMT or placebo PBMT. At the end of the 12 treatment sessions, the primary and secondary outcomes of the study participants will be reassessed by the same evaluator who performed the baseline assessment. The 3, 6 and 12-month follow-ups will be performed by telephone by the same evaluator who carried out the other evaluations. All of the questionnaires that will be used in the present study have been fully tested for their measurement properties.<xref rid="R53" ref-type="bibr">53 55</xref> These measurement properties were also tested over the phone. Therefore, we are confident that the assessments are reliable.</p></sec><sec id="s2k"><title>Statistical analysis</title><p>The statistical analysis will be conducted following the principles of intention-to-treat analysis.<xref rid="R58" ref-type="bibr">58</xref> The normality of the data will be tested by visual inspection of histograms and the characterisation of the participants will be calculated using descriptive statistical tests. The between-group differences (treatment effects) and their respective 95% CIs will be calculated by using mixed linear models<xref rid="R59" ref-type="bibr">59</xref> using the group-by-time interaction terms. The analyses will be performed using SPSS V.19.</p></sec><sec id="s2l"><title>Ethics</title><p>The present study was approved by the Research Ethics Committee of Universidade Cidade de S&#x000e3;o Paulo under number 1.964.094. All patients eligible for the study will be informed by study assessors of the objectives and will be required to complete the informed consent form (see online <xref ref-type="supplementary-material" rid="SP1">supplementary appendix 1</xref>), as determined by Brazilian National Health Council Resolution 196/96.</p><supplementary-material content-type="local-data" id="SP1"><object-id pub-id-type="doi">10.1136/bmjopen-2017-017202.supp1</object-id><caption><title>Supplementary Appendix 1</title></caption><p>
<inline-supplementary-material id="ss1" xlink:href="bmjopen-2017-017202supp001.pdf" mimetype="application" mime-subtype="pdf" content-type="local-data"/>
</p></supplementary-material><p>Research personnel will take all appropriate and customary steps to ensure that data remain secure and that patient privacy and confidentiality will be maintained.</p></sec><sec id="s2m"><title>Dissemination policy</title><p>The study will be disseminated through publication in peer-reviewed international journals, as well as presentations at national and international conferences.</p></sec></sec><sec sec-type="discussion" id="s3"><title>Discussion</title><p>Chronic LBP is a condition that is often associated with disability, emotional alterations and absenteeism from work.<xref rid="R8" ref-type="bibr">8</xref> Since chronic LBP is very prevalent,<xref rid="R11" ref-type="bibr">11</xref> it has a great financial impact, generating high costs, both direct and indirect.<xref rid="R60" ref-type="bibr">60</xref> This fact demonstrates the importance of the constant investigation of more suitable treatments for LBP, aiming at the well-being of the patient and the reduction of expenses for health systems.</p><p>PBMT is one of the interventions recommended for the treatment of chronic LBP,<xref rid="R31" ref-type="bibr">31</xref> however, it is a relatively recent therapy given that the first clinical trial investigating its effects on LBP was published in 1999.<xref rid="R18" ref-type="bibr">18</xref> Since then, there are still conflicts in the literature about PBMT in LBP. Although there is evidence that PBMT is no better than placebo treatment on pain and disability in a mixed sample of patients with acute and chronic LBP,<xref rid="R32" ref-type="bibr">32</xref> some studies have demonstrated the efficacy of PBMT in chronic and acute LBP.<xref rid="R18" ref-type="bibr">18&#x02013;21</xref> Nevertheless, there are still issues to be clarified about its efficacy, as there are no high-quality methodological studies that test PBMT versus placebo in LBP patients. To date, studies evaluating the effects of PBMT on chronic non-specific LBP have not been prospectively registered<xref rid="R18" ref-type="bibr">18&#x02013;21 32</xref>; have a small sample size<xref rid="R18" ref-type="bibr">18 19 21 32</xref> and have high risk of bias. In addition, none of the studies were either triple blinded or were analysed using intention-to-treat principles.</p><p>It is extremely important to carry out studies with high methodological quality aimed at contributing to a better understanding of the effects of PBMT on LBP. Only then will it be possible to determine whether PBMT can be used as one of the treatments of choice for LBP. If the effectiveness of PBMT in LBP is confirmed, it could be used as an alternative method to NSAIDs or opioids, for example, since it causes similar or superior effects to these drugs, shown in other chronic musculoskeletal disorders,<xref rid="R61" ref-type="bibr">61 62</xref> without the presence of known adverse effects at present. We believe that, by providing relevant and compelling information about PBMT, we will contribute to a safer and more effective clinical practice.</p><p>Nevertheless, it is important to highlight that PBMT presents a biphasic dose&#x02013;response pattern, that is, within a therapeutic window (dose range) the biostimulation effects can be seen. Very low doses may not trigger responses in the irradiated tissue, whereas very high doses may cause inhibition.<xref rid="R52" ref-type="bibr">52</xref> In addition, the power and time of irradiation are also extremely important parameters to obtain better results with the PBMT.<xref rid="R63" ref-type="bibr">63</xref> Therefore, the choice of PBMT parameters is essential for obtaining positive results and represents an important challenge in treating any musculoskeletal disorder. To date, there is great heterogeneity in the parameters of PBMT used for the treatment of LBP, and it is not possible to conclude the best dose for the treatment of this disorder. Thus, our parameters were adapted from the best evidence available<xref rid="R42" ref-type="bibr">42</xref> and took into consideration the dosage recommended by World Association for Laser Therapy.<xref rid="R63" ref-type="bibr">63</xref> Therefore, although we believe that the dosage chosen for the present study is the most likely to be effective in triggering the expected results, a limitation of our study is that we will test only one dose of PBMT.</p><p>The present study can be considered to have high methodological quality, since it is a randomised, controlled and prospectively registered clinical trial. In addition, one of the strengths of the study is that it is triple blinded, that is, evaluators, therapists and patients will be blinded to interventions over the course of the study. Finally, the sample size was calculated to provide the appropriate statistical power to detect precise differences in the primary outcomes of the study. Therefore, we believe that this study will contribute to the evidence-based practice of PBMT in patients with chronic LBP.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="d35e167" content-type="local-data"><caption><title>Reviewer comments</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2017-017202.reviewer_comments.pdf"/></supplementary-material><supplementary-material id="d35e168" content-type="local-data"><caption><title>Author's manuscript</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="bmjopen-2017-017202.draft_revisions.pdf"/></supplementary-material></sec></body><back><fn-group><fn fn-type="other"><p><bold>Contributors:</bold> SST and LOPC contributed to the concept and design of the study and established the hypothesis and wrote the original proposal. SST, LCMC, LSG, ACA, DPN, FCM, MAA and LOPC contributed significantly in creating the manuscript. LCMC and LOPC performed critical revisions of the manuscript. SST, LCMC and LOPC wrote the final version of the manuscript. All authors read and approved the final version of the manuscript.</p></fn><fn fn-type="other"><p><bold>Funding:</bold> This work was supported by FAPESP (postdoctoral scholarship of Shaiane Silva Tomazoni) grant number 2016/10265-0.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None declared.</p></fn><fn fn-type="other"><p><bold>Ethics approval:</bold> Research Ethics Committee of Universidade Cidade de S&#x000e3;o Paulo (UNICID) under number 1.964.094.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tulder</surname><given-names>MV</given-names></name></person-group>
<article-title>Chapter 1. European guidelines</article-title>. <source>Eur Spine J</source>
<year>2006</year>;<volume>15</volume>:<fpage>134</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal">
<article-title>American Academy Of Orthopaedic Surgeons. US Bone and Joint Decade - The Burden of Musculoskeletal Diseases in the United States</article-title>. <source>Rosemont, IL, USA</source>
<year>2008</year>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dagenais</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Caro</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Haldeman</surname><given-names>S</given-names></name></person-group>
<article-title>A systematic review of low back pain cost of illness studies in the United States and internationally</article-title>. <source>Spine J</source>
<year>2008</year>;<volume>8</volume>:<fpage>8</fpage>&#x02013;<lpage>20</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.spinee.2007.10.005">doi:10.1016/j.spinee.2007.10.005</ext-link>
<pub-id pub-id-type="pmid">18164449</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>AD</given-names></name></person-group>
<article-title>Measuring the global burden of disease</article-title>. <source>N Engl J Med</source>
<year>2013</year>;<volume>369</volume>:<fpage>448</fpage>&#x02013;<lpage>57</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMra1201534">doi:10.1056/NEJMra1201534</ext-link>
<pub-id pub-id-type="pmid">23902484</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hoy</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bain</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>A systematic review of the global prevalence of low back pain</article-title>. <source>Arthritis Rheum</source>
<year>2012</year>;<volume>64</volume>:<fpage>2028</fpage>&#x02013;<lpage>37</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/art.34347">doi:10.1002/art.34347</ext-link>
<pub-id pub-id-type="pmid">22231424</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Henschke</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Maher</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Refshauge</surname><given-names>KM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prognosis in patients with recent onset low back pain in Australian primary care: inception cohort study</article-title>. <source>BMJ</source>
<year>2008</year>;<volume>337</volume>:<fpage>a171</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.a171">doi:10.1136/bmj.a171</ext-link>
<pub-id pub-id-type="pmid">18614473</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Maher</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>McAuley</surname><given-names>JH</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prognosis for patients with chronic low back pain: inception cohort study</article-title>. <source>BMJ</source>
<year>2009</year>;<volume>339</volume>:<fpage>b3829</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.b3829">doi:10.1136/bmj.b3829</ext-link>
<pub-id pub-id-type="pmid">19808766</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal">
<article-title>Da C Menezes Costa L, Maher CG, Hancock MJ, Mcauley JH, Herbert RD, Costa LO. The prognosis of acute and persistent low-back pain: a meta-analysis</article-title>. <source>CMAJ</source>
<year>2012</year>;<volume>184</volume>:<fpage>E613</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">22586331</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Beattie</surname><given-names>PF</given-names></name>, <name name-style="western"><surname>Silfies</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Jordon</surname><given-names>M</given-names></name></person-group>
<article-title>The evolving role of physical therapists in the long-term management of chronic low back pain: longitudinal care using assisted self-management strategies</article-title>. <source>Braz J Phys Ther</source>
<year>2016</year>;<volume>20</volume>:<fpage>580</fpage>&#x02013;<lpage>91</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/bjpt-rbf.2014.0180">doi:10.1590/bjpt-rbf.2014.0180</ext-link>
<pub-id pub-id-type="pmid">28001268</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Medeiros</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>LOP</given-names></name>, <name name-style="western"><surname>Added</surname><given-names>MAN</given-names></name>, <etal>et al</etal></person-group>
<article-title>Longitudinal monitoring of patients with chronic low back pain during physical therapy treatment using the STarT back screening tool</article-title>. <source>J Orthop Sports Phys Ther</source>
<year>2017</year>;<volume>47</volume>:<fpage>314</fpage>&#x02013;<lpage>23</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2519/jospt.2017.7199">doi:10.2519/jospt.2017.7199</ext-link>
<pub-id pub-id-type="pmid">28355979</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Maher</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Underwood</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Buchbinder</surname><given-names>R</given-names></name></person-group>
<article-title>Non-specific low back pain</article-title>. <source>Lancet</source>
<year>2017</year>;<volume>389</volume>:<fpage>736</fpage>&#x02013;<lpage>47</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(16)30970-9">doi:10.1016/S0140-6736(16)30970-9</ext-link>
<pub-id pub-id-type="pmid">27745712</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bjordal</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Ljunggren</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Klovning</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials</article-title>. <source>BMJ</source>
<year>2004</year>;<volume>329</volume>:<fpage>1317</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.38273.626655.63">doi:10.1136/bmj.38273.626655.63</ext-link>
<pub-id pub-id-type="pmid">15561731</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chou</surname><given-names>R</given-names></name></person-group>
<article-title>Pharmacological management of low back pain</article-title>. <source>Drugs</source>
<year>2010</year>;<volume>70</volume>:<fpage>387</fpage>&#x02013;<lpage>402</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2165/11318690-000000000-00000">doi:10.2165/11318690-000000000-00000</ext-link>
<pub-id pub-id-type="pmid">20205483</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dagenais</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tricco</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Haldeman</surname><given-names>S</given-names></name></person-group>
<article-title>Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines</article-title>. <source>Spine J</source>
<year>2010</year>;<volume>10</volume>:<fpage>514</fpage>&#x02013;<lpage>29</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.spinee.2010.03.032">doi:10.1016/j.spinee.2010.03.032</ext-link>
<pub-id pub-id-type="pmid">20494814</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Van Middelkoop</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rubinstein</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Kuijpers</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain</article-title>. <source>Eur Spine J</source>
<year>2011</year>;<volume>20</volume>:<fpage>19</fpage>&#x02013;<lpage>39</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00586-010-1518-3">doi:10.1007/s00586-010-1518-3</ext-link>
<pub-id pub-id-type="pmid">20640863</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bertagnoli</surname><given-names>R</given-names></name></person-group>
<article-title>Disc surgery in motion</article-title>. <source>SpineLine</source>
<year>2004</year>;<volume>5</volume>:<fpage>23</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sanders</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Rucker</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>KO</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical practice guidelines for chronic non-malignant pain syndrome patients</article-title>. <source>J Back Musculoskelet Rehabil</source>
<year>1995</year>;<volume>5</volume>:<fpage>115</fpage>&#x02013;<lpage>20</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3233/BMR-1995-5204">doi:10.3233/BMR-1995-5204</ext-link>
<pub-id pub-id-type="pmid">24572192</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Basford</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Sheffield</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Harmsen</surname><given-names>WS</given-names></name></person-group>
<article-title>Laser therapy: a randomized, controlled trial of the effects of low-intensity Nd:YAG laser irradiation on musculoskeletal back pain</article-title>. <source>Arch Phys Med Rehabil</source>
<year>1999</year>;<volume>80</volume>:<fpage>647</fpage>&#x02013;<lpage>52</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0003-9993(99)90167-3">doi:10.1016/S0003-9993(99)90167-3</ext-link>
<pub-id pub-id-type="pmid">10378490</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gur</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Karakoc</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cevik</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group>
<article-title>Efficacy of low power laser therapy and exercise on pain and functions in cParameters for SE25&#x02122; and LaserShower&#x02122; cluster probehronic low back pain</article-title>. <source>Lasers Surg Med</source>
<year>2003</year>;<volume>32</volume>:<fpage>233</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/lsm.10134">doi:10.1002/lsm.10134</ext-link>
<pub-id pub-id-type="pmid">12605431</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Konstantinovic</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Kanjuh</surname><given-names>ZM</given-names></name>, <name name-style="western"><surname>Milovanovic</surname><given-names>AN</given-names></name>, <etal>et al</etal></person-group>
<article-title>Acute low back pain with radiculopathy: a double-blind, randomized, placebo-controlled study</article-title>. <source>Photomed Laser Surg</source>
<year>2010</year>;<volume>28</volume>:<fpage>553</fpage>&#x02013;<lpage>60</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/pho.2009.2576">doi:10.1089/pho.2009.2576</ext-link>
<pub-id pub-id-type="pmid">20001318</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Vallone</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Benedicenti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sorrenti</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effect of diode laser in the treatment of patients with nonspecific chronic low back pain: a randomized controlled trial</article-title>. <source>Photomed Laser Surg</source>
<year>2014</year>;<volume>32</volume>:<fpage>490</fpage>&#x02013;<lpage>4</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/pho.2014.3715">doi:10.1089/pho.2014.3715</ext-link>
<pub-id pub-id-type="pmid">25141218</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anders</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lanzafame</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Arany</surname><given-names>PR</given-names></name></person-group>
<article-title>Low-level light/laser therapy versus photobiomodulation therapy</article-title>. <source>Photomed Laser Surg</source>
<year>2015</year>;<volume>33</volume>:<fpage>183</fpage>&#x02013;<lpage>4</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/pho.2015.9848">doi:10.1089/pho.2015.9848</ext-link>
<pub-id pub-id-type="pmid">25844681</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tullberg</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Alstergren</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Ernberg</surname><given-names>MM</given-names></name></person-group>
<article-title>Effects of low-power laser exposure on masseter muscle pain and microcirculation</article-title>. <source>Pain</source>
<year>2003</year>;<volume>105</volume>:<fpage>89</fpage>&#x02013;<lpage>96</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0304-3959(03)00166-0">doi:10.1016/S0304-3959(03)00166-0</ext-link>
<pub-id pub-id-type="pmid">14499424</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Silveira</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Fraga</surname><given-names>DB</given-names></name>, <etal>et al</etal></person-group>
<article-title>Evaluation of mitochondrial respiratory chain activity in muscle healing by low-level laser therapy</article-title>. <source>J Photochem Photobiol B</source>
<year>2009</year>;<volume>95</volume>:<fpage>89</fpage>&#x02013;<lpage>92</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jphotobiol.2009.01.004">doi:10.1016/j.jphotobiol.2009.01.004</ext-link>
<pub-id pub-id-type="pmid">19232497</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Albuquerque-Pontes</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Vieira</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Tomazoni</surname><given-names>SS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effect of pre-irradiation with different doses, wavelengths, and application intervals of low-level laser therapy on cytochrome c oxidase activity in intact skeletal muscle of rats</article-title>. <source>Lasers Med Sci</source>
<year>2015</year>;<volume>30</volume>:<fpage>59</fpage>&#x02013;<lpage>66</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10103-014-1616-2">doi:10.1007/s10103-014-1616-2</ext-link>
<pub-id pub-id-type="pmid">24957189</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>TC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Low-intensity laser irradiation improves the mitochondrial dysfunction of C2C12 induced by electrical stimulation</article-title>. <source>Photomed Laser Surg</source>
<year>2008</year>;<volume>26</volume>:<fpage>197</fpage>&#x02013;<lpage>202</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/pho.2007.2125">doi:10.1089/pho.2007.2125</ext-link>
<pub-id pub-id-type="pmid">18484910</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Avni</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Levkovitz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Maltz</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Protection of skeletal muscles from ischemic injury: low-level laser therapy increases antioxidant activity</article-title>. <source>Photomed Laser Surg</source>
<year>2005</year>;<volume>23</volume>:<fpage>273</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/pho.2005.23.273">doi:10.1089/pho.2005.23.273</ext-link>
<pub-id pub-id-type="pmid">15954814</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rizzi</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Mauriz</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Freitas Corr&#x000ea;a</surname><given-names>DS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle</article-title>. <source>Lasers Surg Med</source>
<year>2006</year>;<volume>38</volume>:<fpage>704</fpage>&#x02013;<lpage>13</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/lsm.20371">doi:10.1002/lsm.20371</ext-link>
<pub-id pub-id-type="pmid">16799998</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Lopes-Martins</surname><given-names>RAB</given-names></name>, <etal>et al</etal></person-group>
<article-title>Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials</article-title>. <source>The Lancet</source>
<year>2009</year>;<volume>374</volume>:<fpage>1897</fpage>&#x02013;<lpage>908</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(09)61522-1">doi:10.1016/S0140-6736(09)61522-1</ext-link>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Glazov</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yelland</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Emery</surname><given-names>J</given-names></name></person-group>
<article-title>Low-level laser therapy for chronic non-specific low back pain: a meta-analysis of randomised controlled trials</article-title>. <source>Acupunct Med</source>
<year>2016</year>;<volume>34</volume>:<fpage>328</fpage>&#x02013;<lpage>41</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/acupmed-2015-011036">doi:10.1136/acupmed-2015-011036</ext-link>
<pub-id pub-id-type="pmid">27207675</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Qaseem</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wilt</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>McLean</surname><given-names>RM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical Guidelines Committee of the American College of Physicians. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians</article-title>. <source>Ann Intern Med</source>
<year>2017</year>;<volume>166</volume>:<fpage>514</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">28192789</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ay</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dogan</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Evcik</surname><given-names>D</given-names></name></person-group>
<article-title>Is low-level laser therapy effective in acute or chronic low back pain?</article-title>
<source>Clin Rheumatol</source>
<year>2010</year>;<volume>29</volume>:<fpage>905</fpage>&#x02013;<lpage>10</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10067-010-1460-0">doi:10.1007/s10067-010-1460-0</ext-link>
<pub-id pub-id-type="pmid">20414695</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Airaksinen</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Brox</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Cedraschi</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Chapter 4. European guidelines for the management of chronic nonspecific low back pain</article-title>. <source>Eur Spine J</source>
<year>2006</year>;<volume>15</volume>:<fpage>s192</fpage>&#x02013;<lpage>s300</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00586-006-1072-1">doi:10.1007/s00586-006-1072-1</ext-link>
<pub-id pub-id-type="pmid">16550448</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Magee</surname><given-names>DJ</given-names></name></person-group>
<source>Orthopedic physical assessment</source>. <edition>6 Edn</edition>
<publisher-loc>Alberta, Canada</publisher-loc>: <publisher-name>Elsevier</publisher-name>, <year>2008</year>:<fpage>569</fpage>&#x02013;<lpage>618</lpage>.</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Delitto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>George</surname><given-names>SZ</given-names></name>, <name name-style="western"><surname>Van Dillen</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Low Back Pain. Clinical practice guidelines linked to the international classification of functioning, disability, and health from the orthopaedic section of the American Physical Therapy Association</article-title>. <source>J Orthop Sports Phys Ther</source>
<year>2012</year>;<volume>42</volume>:<fpage>A1</fpage>&#x02013;<lpage>A57</lpage>.</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="other">
<person-group person-group-type="author"><name name-style="western"><surname>Manchester</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Glasgow</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>York</surname><given-names>JKM</given-names></name>, <etal>et al</etal></person-group>
<article-title>The Back Book. Clinical guidelines for the management of acute low back pain</article-title>. <year>2002</year>:<fpage>1</fpage>&#x02013;<lpage>-28</lpage>.</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Van Tulder</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bekkering</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care</article-title>. <source>Eur Spine J</source>
<year>2006</year>;<volume>15</volume>:<fpage>s169</fpage>&#x02013;<lpage>s191</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00586-006-1071-2">doi:10.1007/s00586-006-1071-2</ext-link>
<pub-id pub-id-type="pmid">16550447</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Engers</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jellema</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wensing</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Individual patient education for low back pain</article-title>. <source>Cochrane Database Syst Rev</source>
<year>2008</year>;<volume>23</volume>:<fpage>CD004057</fpage>.</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Hancock</surname><given-names>MJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Efficacy of the McKenzie method in patients with chronic nonspecific low back pain: a protocol of randomized placebo-controlled trial</article-title>. <source>Phys Ther</source>
<year>2015</year>;<volume>95</volume>:<fpage>267</fpage>&#x02013;<lpage>73</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2522/ptj.20140208">doi:10.2522/ptj.20140208</ext-link>
<pub-id pub-id-type="pmid">25278336</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Hancock</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>LCM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Efficacy of the mechanical diagnosis and therapy in patients with chronic nonspecific low back pain: a randomized placebo controlled trial. 2017</article-title>. <source>Brit J Sports Med</source>. <comment>In Press</comment>.</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Grandin&#x000e9;tti</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>DS</given-names></name>, <etal>et al</etal></person-group>
<article-title>The thermal impact of phototherapy with concurrent super-pulsed lasers and red and infrared LEDs on human skin</article-title>. <source>Lasers Med Sci</source>
<year>2015</year>;<volume>30</volume>:<fpage>1575</fpage>&#x02013;<lpage>81</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10103-015-1755-0">doi:10.1007/s10103-015-1755-0</ext-link>
<pub-id pub-id-type="pmid">25987340</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leal-Junior</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Saltmarche</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Adjunctive use of combination of super-pulsed laser and light-emitting diodes phototherapy on nonspecific knee pain: double-blinded randomized placebo-controlled trial</article-title>. <source>Lasers Med Sci</source>
<year>2014</year>;<volume>29</volume>:<fpage>1839</fpage>&#x02013;<lpage>47</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10103-014-1592-6">doi:10.1007/s10103-014-1592-6</ext-link>
<pub-id pub-id-type="pmid">24844921</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>LO</given-names></name>, <name name-style="western"><surname>Maher</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Latimer</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Motor control exercise for chronic low back pain: a randomized placebo-controlled trial</article-title>. <source>Phys Ther</source>
<year>2009</year>;<volume>89</volume>:<fpage>1275</fpage>&#x02013;<lpage>86</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2522/ptj.20090218">doi:10.2522/ptj.20090218</ext-link>
<pub-id pub-id-type="pmid">19892856</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>SP</given-names></name></person-group>
<article-title>Efficacy of segmental stabilization exercise for lumbar segmental instability in patients with mechanical low back pain: a randomized placebo controlled crossover study</article-title>. <source>N Am J Med Sci</source>
<year>2011</year>;<volume>3</volume>:<fpage>456</fpage>&#x02013;<lpage>61</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4297/najms.2011.3456">doi:10.4297/najms.2011.3456</ext-link><pub-id pub-id-type="pmid">22363083</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ebadi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ansari</surname><given-names>NN</given-names></name>, <name name-style="western"><surname>Naghdi</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>The effect of continuous ultrasound on chronic non-specific low back pain: a single blind placebo-controlled randomized trial</article-title>. <source>BMC Musculoskelet Disord</source>
<year>2012</year>;<volume>13</volume>:<fpage>192</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2474-13-192">doi:10.1186/1471-2474-13-192</ext-link>
<pub-id pub-id-type="pmid">23031570</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Balthazard</surname><given-names>P</given-names></name>, <name name-style="western"><surname>de Goumoens</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rivier</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>Manual therapy followed by specific active exercises versus a placebo followed by specific active exercises on the improvement of functional disability in patients with chronic non specific low back pain: a randomized controlled trial</article-title>. <source>BMC Musculoskelet Disord</source>
<year>2012</year>;<volume>13</volume>:<fpage>162</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2474-13-162">doi:10.1186/1471-2474-13-162</ext-link>
<pub-id pub-id-type="pmid">22925609</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Parreira</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group>
<article-title>Kinesio taping to generate skin convolutions is not better than sham taping for people with chronic non-specifc low back pain: a randomised trial</article-title>. <source>J Physiother</source>
<year>2014</year>;<volume>60</volume>:<fpage>90</fpage>&#x02013;<lpage>6</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jphys.2014.05.003">doi:10.1016/j.jphys.2014.05.003</ext-link>
<pub-id pub-id-type="pmid">24952836</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Luz J&#x000fa;nior</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Sousa</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Neves</surname><given-names>LA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Kinesio Taping&#x000ae; is not better than placebo in reducing pain and disability in patients with chronic non-specific low back pain: a randomized controlled trial</article-title>. <source>Braz J Phys Ther</source>
<year>2015</year>;<volume>19</volume>:<fpage>482</fpage>&#x02013;<lpage>90</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/bjpt-rbf.2014.0128">doi:10.1590/bjpt-rbf.2014.0128</ext-link>
<pub-id pub-id-type="pmid">26647750</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Antonialli</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>De Marchi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tomazoni</surname><given-names>SS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Phototherapy in skeletal muscle performance and recovery after exercise: effect of combination of super-pulsed laser and light-emitting diodes</article-title>. <source>Lasers Med Sci</source>
<year>2014</year>;<volume>29</volume>:<fpage>1967</fpage>&#x02013;<lpage>76</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10103-014-1611-7">doi:10.1007/s10103-014-1611-7</ext-link>
<pub-id pub-id-type="pmid">24942380</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Miranda</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>de Oliveira</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Antonialli</surname><given-names>FC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Phototherapy with combination of super-pulsed laser and light-emitting diodes is beneficial in improvement of muscular performance (strength and muscular endurance), dyspnea, and fatigue sensation in patients with chronic obstructive pulmonary disease</article-title>. <source>Lasers Med Sci</source>
<year>2015</year>;<volume>30</volume>:<fpage>437</fpage>&#x02013;<lpage>43</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10103-014-1690-5">doi:10.1007/s10103-014-1690-5</ext-link>
<pub-id pub-id-type="pmid">25413975</pub-id></mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chow</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Armati</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Laakso</surname><given-names>EL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Inhibitory effects of laser irradiation on peripheral mammalian nerves and relevance to analgesic effects: a systematic review</article-title>. <source>Photomed Laser Surg</source>
<year>2011</year>;<volume>29</volume>:<fpage>365</fpage>&#x02013;<lpage>81</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/pho.2010.2928">doi:10.1089/pho.2010.2928</ext-link>
<pub-id pub-id-type="pmid">21456946</pub-id></mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Biphasic dose response in low level light therapy - an update</article-title>. <source>Dose Response</source>
<year>2011</year>;<volume>9</volume>:<fpage>602</fpage>&#x02013;<lpage>618</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2203/dose-response.11-009.Hamblin">doi:10.2203/dose-response.11-009.Hamblin</ext-link>
<pub-id pub-id-type="pmid">22461763</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>LO</given-names></name>, <name name-style="western"><surname>Maher</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Latimer</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinimetric testing of three self-report outcome measures for low back pain patients in Brazil: which one is the best?</article-title>
<source>Spine</source>
<year>2008</year>;<volume>33</volume>:<fpage>2459</fpage>&#x02013;<lpage>63</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/BRS.0b013e3181849dbe">doi:10.1097/BRS.0b013e3181849dbe</ext-link>
<pub-id pub-id-type="pmid">18923324</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nusbaum</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Natour</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ferraz</surname><given-names>MB</given-names></name>, <etal>et al</etal></person-group>
<article-title>Translation, adaptation and validation of the Roland-Morris questionnaire--Brazil Roland-Morris</article-title>. <source>Braz J Med Biol Res</source>
<year>2001</year>;<volume>34</volume>:<fpage>203</fpage>&#x02013;<lpage>10</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1590/S0100-879X2001000200007">doi:10.1590/S0100-879X2001000200007</ext-link>
<pub-id pub-id-type="pmid">11175495</pub-id></mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>LO</given-names></name>, <name name-style="western"><surname>Maher</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Latimer</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Psychometric characteristics of the Brazilian-Portuguese versions of the functional rating index and the Roland Morris disability questionnaire</article-title>. <source>Spine</source>
<year>2007</year>;<volume>32</volume>:<fpage>1902</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/BRS.0b013e31811eab33">doi:10.1097/BRS.0b013e31811eab33</ext-link>
<pub-id pub-id-type="pmid">17762300</pub-id></mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chatman</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Hyams</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Neel</surname><given-names>JM</given-names></name>, <etal>et al</etal></person-group>
<article-title>The Patient-Specific Functional Scale: measurement properties in patients with knee dysfunction</article-title>. <source>Phys Ther</source>
<year>1997</year>;<volume>77</volume>:<fpage>820</fpage>&#x02013;<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ptj/77.8.820">doi:10.1093/ptj/77.8.820</ext-link>
<pub-id pub-id-type="pmid">9256870</pub-id></mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Pengel</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Refshauge</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Maher</surname><given-names>CG</given-names></name></person-group>
<article-title>Responsiveness of pain, disability, and physical impairment outcomes in patients with low back pain</article-title>. <source>Spine</source>
<year>2004</year>;<volume>29</volume>:<fpage>879</fpage>&#x02013;<lpage>83</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00007632-200404150-00011">doi:10.1097/00007632-200404150-00011</ext-link>
<pub-id pub-id-type="pmid">15082988</pub-id></mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Elkins</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Moseley</surname><given-names>AM</given-names></name></person-group>
<article-title>Intention-to-treat analysis</article-title>. <source>J Physiother</source>
<year>2015</year>;<volume>61</volume>:<fpage>165</fpage>&#x02013;<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jphys.2015.05.013">doi:10.1016/j.jphys.2015.05.013</ext-link>
<pub-id pub-id-type="pmid">26096012</pub-id></mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Twisk</surname><given-names>JWR</given-names></name></person-group>
<source>Applied longitudinal data analysis for epidemiology: a practical guide</source>, <year>2003</year>:. <comment>ISBN: 0521819768</comment>.</mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>WD</given-names></name></person-group>
<article-title>Low back pain in Australian adults: the economic burden</article-title>. <source>Asia Pac J Public Health</source>
<year>2003</year>;<volume>15</volume>:<fpage>79</fpage>&#x02013;<lpage>87</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/101053950301500202">doi:10.1177/101053950301500202</ext-link>
<pub-id pub-id-type="pmid">15038680</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tomazoni</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Leal-Junior</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Frigo</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Isolated and combined effects of photobiomodulation therapy, topical nonsteroidal anti-inflammatory drugs, and physical activity in the treatment of osteoarthritis induced by papain</article-title>. <source>J Biomed Opt</source>
<year>2016</year>;<volume>21</volume>:<fpage>108001</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1117/1.JBO.21.10.108001">doi:10.1117/1.JBO.21.10.108001</ext-link>
<pub-id pub-id-type="pmid">27752702</pub-id></mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tomazoni</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Leal-Junior</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Pallotta</surname><given-names>RC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effects of photobiomodulation therapy, pharmacological therapy, and physical exercise as single and/or combined treatment on the inflammatory response induced by experimental osteoarthritis</article-title>. <source>Lasers Med Sci</source>
<year>2017</year>;<volume>32</volume>:<fpage>101</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10103-016-2091-8">doi:10.1007/s10103-016-2091-8</ext-link>
<pub-id pub-id-type="pmid">27726040</pub-id></mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="web">
<chapter-title>World Association for Laser Therapy - WALT (2010): Dosage recommendations</chapter-title>
<source>Recommended treatment doses for low level laser therapy</source>. <uri xlink:href="http://www.walt.nu/dosage-recommendations.html">http://www.walt.nu/dosage-recommendations.html</uri> (<comment>accessed 30 May 2017</comment>).</mixed-citation></ref></ref-list></back></article>